Technology News and Research

RSS

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

Two market leading companies in the field of cell based assays and predictive toxicology today announced a new product collaboration. Medicyte (inventors of the upcyte® technology) and Reinnervate (market leaders in the growing field of 3D cell culture) said they will work together to combine their upcyte® and Alvetex®Scaffold technologies to bring next generation cell bases assays to the biopharma and academic research markets.

9 Jul 2012

Long Beach Memorial uses Toshiba's Aquilion ONE to expand stroke care capabilities

To expand its stroke care capabilities for fast diagnoses and more accurate treatment, Long Beach Memorial, a primary stroke care center for MemorialCare Health System, is using Toshiba's Aquilion ONE dynamic volume CT system for both acute stroke diagnoses and interventional planning.

9 Jul 2012

Merck, PDS Biotechnology enter licensing agreement for Versamune

PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.

9 Jul 2012

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

Australian healthcare company Medical Developments International (MDI) and CSIRO have signed a technology deal to develop a new production process for the drug methoxyflurane - the pain-relieving ingredient used in Penthrox™ (commonly known as the green whistle).

9 Jul 2012

UC Riverside receives NSF grant to address water quantity and quality issues

Water is likely to become an even more important factor in determining human well-being in the near future as the world's population continues to increase. While it is clear that the demand for water will steadily rise, it also appears that water supply could decline as a result of major shifts in the world's climate.

8 Jul 2012

UNN, UM establish firm foundation for mutual collaborations

A delegation from the University of Nigeria (UNN) has just completed a week in key laboratories and boardrooms at the University of Maryland's Baltimore campus exploring educational exchanges between the two universities.

8 Jul 2012

Roundup: Feds rank Texas last in health care delivery; Mass. health care costs eat almost 43 percent of state budget

Texas ranked dead last in the federal government's latest report card on the delivery of health services, falling short in areas ranging from acute hospital care to home treatment of the chronically ill. Texas scored 31.61 -- less than half of top-ranked Minnesota's 67.31 -- out of a possible 100 points in the Agency for Healthcare Research and Quality annual rankings.

7 Jul 2012

New optical microscope identifies rare breast cancer cells

The ability to distinguish and isolate rare cells from among a large population of assorted cells has become increasingly important for the early detection of disease and for monitoring disease treatments.

7 Jul 2012

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death.

6 Jul 2012

ADCT, CRT sign agreements to develop ADCs against cancer

Cancer Research Technology (CRT), the commercial arm of Cancer Research UK, and Switzerland-based ADC Therapeutics Sarl (ADCT) announce today that they have signed agreements to develop cancer treatments called Antibody Drug Conjugates (ADCs) using CRT antibodies and peptides, and ADCT's 'warhead' and linker chemistries.

6 Jul 2012

TRIL Clinic's novel technologies could increase accuracy in assessment of falls risk in older people

1 in 3 people over the age of 65 suffer from a fall every year in Ireland. Two-thirds of this group fall again within 6 months, leading to risk of hospitalisation and significant health decline. Today in St James's Hospital, Dublin, Seán Sherlock T.D., Minister for Research and Innovation, launched the TRIL Clinic's novel suite of technologies that could potentially increase accuracy in the assessment of falls risk in older people.

6 Jul 2012

Jeff Davis Imaging installs Vantage Titan 3T from Toshiba

To provide patients with advanced 3T MR imaging, Jeff Davis Imaging, which is located within Jennings American Legion Hospital in Jennings, La., installed the Vantage Titan 3T from Toshiba America Medical Systems, Inc.

5 Jul 2012

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

5 Jul 2012

AIDS battle: stretching use of anti-HIV drugs

A Johns Hopkins expert in the drug treatment of HIV disease and AIDS is spearheading an international effort to radically shift the manufacturing and prescribing of combination therapies widely credited in the last decade for keeping the disease in check for 8 million of the 34 million infected people worldwide.

5 Jul 2012

Non-invasive absolute intracranial pressure value meter shown to be accurate in clinical settings

The results of independent clinical assessment – prospective study of innovative non-invasive absolute intracranial pressure (ICP) value (mmHg) meter were recently published in the journal Neurology (The official journal of the American Academy of Neurology). This is the first prospective comparative clinical study of a non-invasive ICP measurement method that shows accuracy and precision which is acceptable for clinical practice.

5 Jul 2012

Study shows cells from different Parkinson’s patients have unique drug responses

Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments.

5 Jul 2012

Researchers use maternal blood sample to sequence genome of an unborn baby

Researchers at the Stanford University School of Medicine have for the first time sequenced the genome of an unborn baby using only a blood sample from the mother.

5 Jul 2012

Anti-cancer activity of HuCAL antibody revealed by new data from OncoMed

MorphoSys AG's (FSE: MOR; Prime Standard Segment, TecDAX) partner OncoMed Pharmaceuticals today announced that Proceedings of the National Academy of Sciences of the United States of America (PNAS) has published online data demonstrating the potent anti-cancer activity of OMP-18R5, a HuCAL antibody targeting the Wnt pathway, in multiple preclinical human tumor models. OMP-18R5 is currently in Phase 1 clinical testing.

5 Jul 2012

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

4 Jul 2012

Madrid, Accenture implement HORUS system

Accenture and Madrid Health Service have fully implemented the Madrid Electronic Health Record (HORUS) system that captures all patient information into a single, integrated record for 26,000 clinicians to access across all parts of the regional healthcare system.

4 Jul 2012

Technology News and Research

Next generation predictive 3D cell toxicity assays to be developed by Medicyte GmbH and Reinnervate Ltd

Long Beach Memorial uses Toshiba's Aquilion ONE to expand stroke care capabilities

Merck, PDS Biotechnology enter licensing agreement for Versamune

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

UC Riverside receives NSF grant to address water quantity and quality issues

UNN, UM establish firm foundation for mutual collaborations

Roundup: Feds rank Texas last in health care delivery; Mass. health care costs eat almost 43 percent of state budget

New optical microscope identifies rare breast cancer cells

Novel biomimetic strategy can dissolve blood clots before they cause serious damage or even death

ADCT, CRT sign agreements to develop ADCs against cancer

TRIL Clinic's novel technologies could increase accuracy in assessment of falls risk in older people

Jeff Davis Imaging installs Vantage Titan 3T from Toshiba

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

AIDS battle: stretching use of anti-HIV drugs

Non-invasive absolute intracranial pressure value meter shown to be accurate in clinical settings

Study shows cells from different Parkinson’s patients have unique drug responses

Researchers use maternal blood sample to sequence genome of an unborn baby

Anti-cancer activity of HuCAL antibody revealed by new data from OncoMed

Cancer Therapeutics reveals proof of concept for second development drug

Madrid, Accenture implement HORUS system

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News